Remicade (infliximab) has the most literature on healing perianal disease; Humira also has good evidence but less literature; Stelara and vedolizumab are sometimes used with less information available.
Remicade (infliximab) has the most literature on healing perianal disease; Humira also has good evidence but less literature; Stelara and vedolizumab are sometimes used with less information available.
Remicade (infliximab) has the most literature on healing perianal disease; Humira also has good evidence but less literature; Stelara and vedolizumab are sometimes used with less information available.
Remicade (infliximab) has the most literature on healing perianal disease; Humira also has good evidence but less literature; Stelara and vedolizumab are sometimes used with less information available.
clinicalIt is common to have perianal disease in Crohn's; this patient had a delay in diagnosis and had perianal disease for quite some time with multiple skin tags and fissures.↗
▶Ep 115 · 7:24
clinicalIt is common to have perianal disease in Crohn's; this patient had a delay in diagnosis and had perianal disease for quite some time with multiple skin tags and fissures.↗
▶Ep 115 · 17:54
clinicalSetons should remain in place for at least 6 months to allow the inflammatory tract to become non-inflammatory.↗
▶Ep 115 · 17:54
clinicalSetons should remain in place for at least 6 months to allow the inflammatory tract to become non-inflammatory.↗
▶Ep 115 · 18:45
clinicalFor recurrent patients requiring repeat seton placement, repeat imaging should be obtained before seton removal.↗
▶Ep 115 · 18:45
clinicalFor recurrent patients requiring repeat seton placement, repeat imaging should be obtained before seton removal.↗
▶Ep 115 · 19:12
epidemiologicalLiterature shows about a 10% response rate for perianal fistulas even without biologics if a seton is placed and removed, with much better outcomes with biologics.↗
▶Ep 115 · 19:12
epidemiologicalLiterature shows about a 10% response rate for perianal fistulas even without biologics if a seton is placed and removed, with much better outcomes with biologics.↗
▶Ep 115 · 20:27
clinicalRemicade (infliximab) has the most literature on healing perianal disease; Humira also has good evidence but less literature; Stelara and vedolizumab are sometimes used with less information available.↗
▶Ep 115 · 20:27
clinicalRemicade (infliximab) has the most literature on healing perianal disease; Humira also has good evidence but less literature; Stelara and vedolizumab are sometimes used with less information available.↗
clinicalIt is common to have perianal disease in Crohn's; this patient had a delay in diagnosis and had perianal disease for quite some time with multiple skin tags and fissures.↗
▶Ep 1 · 7:24
clinicalIt is common to have perianal disease in Crohn's; this patient had a delay in diagnosis and had perianal disease for quite some time with multiple skin tags and fissures.↗
▶Ep 1 · 17:54
clinicalSetons should remain in place for at least 6 months to allow the inflammatory tract to become non-inflammatory.↗
▶Ep 1 · 17:54
clinicalSetons should remain in place for at least 6 months to allow the inflammatory tract to become non-inflammatory.↗
▶Ep 1 · 18:45
clinicalFor recurrent patients requiring repeat seton placement, repeat imaging should be obtained before seton removal.↗
▶Ep 1 · 18:45
clinicalFor recurrent patients requiring repeat seton placement, repeat imaging should be obtained before seton removal.↗
▶Ep 1 · 19:12
epidemiologicalLiterature shows about a 10% response rate for perianal fistulas even without biologics if a seton is placed and removed, with much better outcomes with biologics.↗
▶Ep 1 · 19:12
epidemiologicalLiterature shows about a 10% response rate for perianal fistulas even without biologics if a seton is placed and removed, with much better outcomes with biologics.↗
▶Ep 1 · 20:27
clinicalRemicade (infliximab) has the most literature on healing perianal disease; Humira also has good evidence but less literature; Stelara and vedolizumab are sometimes used with less information available.↗
▶Ep 1 · 20:27
clinicalRemicade (infliximab) has the most literature on healing perianal disease; Humira also has good evidence but less literature; Stelara and vedolizumab are sometimes used with less information available.↗
